← Open Payments lookup

DAVID PERZ: Open Payments

NPI 1558450684 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,647 in 90 payments from 20 companies in 2025. Trend: 2023 $1,598 · 2024 $1,482 · 2025 $1,647

Food & beverage: $1,647
CompanyPaymentsAmount
Corcept Therapeutics27$341
AstraZeneca Pharmaceuticals LP9$260
Xeris Pharmaceuticals, Inc.13$186
RECORDATI_RARE_DISEASES_INC.8$174
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$145
Merck Sharp & Dohme LLC3$86
GlaxoSmithKline, LLC.3$57
Lundbeck LLC2$51
Amgen Inc.2$48
Otsuka America Pharmaceutical, Inc.2$46

Products named: Korlym, RECORLEV, ISTURISA, AIRSUPRA, CAPLYTA, REXULTI, FARXIGA, VERQUVO.

Industry payments across CA — which companies pay providers there.